| 1801 |
LUCITAZE |
TAZEMETOSTAT 200 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT AND PEDIATRIC PATIENTS AGED 16 YEARS AND OLDER WITH METASTATIC OR LOCALLY ADVANCED EPITHELIOID SARCOMA NOT ELIGIBLE FOR COMPLETE RESECTION |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1211/24 |
02-OCT-2024 |
01-OCT-2029 |
View |
| 1802 |
LUCITENO |
TENOFOVIR ALAFENAMIDE 25 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION IN ADULTS AND PEDIATRIC PATIENTS 6 YEARS OF AGE AND OLDER AND WEIGHING AT LEAST 25 KG WITH COMPENSATED LIVER DISEASE |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1210/24 |
02-OCT-2024 |
01-OCT-2029 |
View |
| 1803 |
LUCITEPO |
TEPOTINIB 225 MG |
TABLET |
BOTTLE |
FOR THE TREATMENNT OF ADULT PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER HARBORING MESENCHYMAL EPITHELIAL TRANSITION EXON 14 SKIPPING ALTERAONS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1103/24 |
21-JUN-2024 |
20 JUN 2027 |
View |
| 1804 |
LUCITIVO |
TIVOZANIB 0.89 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY ADVANCED RENAL CELL CARCINOMA FOLLOWING TWO OR MORE PRIOR SYSTEMIC THERAPY |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1094/24 |
08-APR-2024 |
07-APR-2027 |
View |
| 1805 |
LUCITIVO |
TIVOZANIB 1.34 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY ADVANCED RENAL CELL CARCINOMA FOLLOWING TWO OR MORE PRIOR SYSTEMIC THERAPY |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1081/24 |
26-Mar-2024 |
25-Mar-2027 |
View |
| 1806 |
LUCITOFA |
TOFACITINIB 5 MG |
TABLET |
BOTTLE |
TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE OR INTOLERANCE TO METHOTREXATE |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
08 L 1185/24 |
22-AUG-2024 |
21-AUG-2027 |
View |
| 1807 |
LUCITRAM |
TRAMETINIB 2 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF BRAF-INHIBITOR TREATMENT-NAÏVE PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA WITH BRAF V600E OR V600K MUTATIONS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1010/23 |
20-SEP-2023 |
19-SEP-2026 |
View |
| 1808 |
LUCITRELAG |
TRELAGLIPTIN 100 MG |
TABLET |
BOTTLE |
AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETE MELLITUS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1143/24 |
12-JUL-2024 |
11-JUL-2027 |
View |
| 1809 |
LUCIUPA |
UPADACITINIB 15 MG |
TABLET |
BOTTLE |
TREATMENT OF ADULT WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAVE HAD AN INADEQUATE RESPONSE OR INTOLERANCE TO ONE OR MORE TNF BLOCKERS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1091/24 |
2024-04-29 |
2027-04-28 |
View |
| 1810 |
LUCIVALGA |
VALGANCICLOVIR 450 MG |
FILM COATED TABLET |
BOTTLE |
FOR TREATMENT OF CMV RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYDROME AND PREVENTION OF CMV DISEASE IN KIDNEY, HEART, AND KIDNEY-PANCREAS TRANSPLANT AT HIGH RISK IN ADULT PATIENTS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1104/24 |
21-JUN-2024 |
20 JUN 2027 |
View |
